The European Centre for Disease Prevention and Control (ECDC) and the European Respiratory Society (ERS) have developed 21 patient-centred standards to guide clinicians and public health workers in their work to ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) in Europe.
People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV often linked to a history of injecting drug use.
In their joint public health Guidance published today, ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), present the evidence on active case finding as a key measure to diagnose communicable diseases early.
The ECDC Calculator- LTBI control in European countries is an Excel tool based on a tuberculosis transmission model with the purpose to assess different screening strategies for latent tuberculosis infection (LTBI).
This tool uses data from four pilot countries to estimate annual tuberculosis incidence and to predict the costs and effect of different LTBI screening strategies over a 20-year period.
A new report published today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe indicates that the number of new tuberculosis (TB) patients has been decreasing at an average rate of 4.3% per year in the WHO European Region over the last decade.
Tuberculosis (TB) has become the world’s leading single infectious disease killer, an unenviable title previously held by HIV/AIDS. It is therefore more important than ever to join forces against TB to successfully reach the goal of ending TB by 2030.